|Bid||83.00 x 1100|
|Ask||83.38 x 3000|
|Day's Range||81.56 - 83.50|
|52 Week Range||65.25 - 90.97|
|Beta (5Y Monthly)||0.44|
|PE Ratio (TTM)||18.41|
|Earnings Date||Feb. 04, 2021|
|Forward Dividend & Yield||2.60 (3.12%)|
|Ex-Dividend Date||Dec. 14, 2020|
|1y Target Est||96.58|
Lilly's (LLY) candidate, donanemab shows slowing of cognitive decline in Alzheimer's disease patients. Novartis (NVS) and Sanofi (SNY) announce M&A deals.
Merck (MRK) closed at $82.17 in the latest trading session, marking a -0.21% move from the prior day.
Merck's (MRK) investigational 15-valent pneumococcal conjugate vaccine, V114 includes pneumococcal serotypes 22F and 33F, which are not included in the currently licensed conjugate vaccines.